IUI with a Partner's Sperm: Who It Helps and What Success Rates Mean

Key Takeaways

IUI puts prepared sperm in the womb near ovulation. It is simpler than IVF and may help if at least one tube is open and the problem is mild or unexplained. The chance per cycle tends to fall with age, and a group figure is not a personal chance. In unexplained infertility, the plan is usually reviewed after three or four well-timed cycles.

Key evidence: ASRM guideline on unexplained infertility (2020) · AUA/ASRM male infertility guideline part II (2020) · ESHRE unexplained infertility guideline

Dr. Aksoy’s Approach

Dr. Aksoy’s Approach: IUI can be a reasonable first step when at least one fallopian tube is open and the fertility problem is mild or unexplained. It should still have a clear review point. After three or four well-timed cycles, we reassess the plan; IVF may be discussed earlier when age, ovarian reserve, tubal factors or sperm parameters make time more important.

What IUI with a Partner’s Sperm Is

IUI places prepared sperm inside the uterus close to ovulation. The lab first concentrates the moving sperm, and a thin catheter then puts them near where fertilisation can occur.

That shortens the sperm’s journey and may help when the cervix is a barrier. Fertilisation itself still happens in the body, not in the laboratory (ASRM 2020 guideline).

A cycle may be natural, or it may use mild ovulation medicine. The choice depends on the diagnosis and how regular the cycles are.

Who Is Most Likely to Benefit

IUI only shortens the route, so the rest of the route has to work. Four checks usually come first:

• Open fallopian tubes: At least one tube must be clear and able to function. If both are blocked, IUI cannot bridge the gap; see blocked fallopian tubes.
• Reliable ovulation: The egg is released on its own, or medicine makes that predictable.
• Enough moving sperm: After lab preparation, an adequate number of motile sperm remain. The AUA/ASRM guideline describes limited chances with IUI below about 5 million motile sperm after processing; the figure is a threshold to weigh, not a hard cut-off (AUA/ASRM 2020 male infertility guideline).
• A fitting diagnosis: The cause may be unexplained, related to the cervix, or linked to mild endometriosis.

IUI may be a less direct option when the sperm count after preparation is low. From about age 38, ASRM notes that in unexplained infertility going straight to IVF may be associated with a higher pregnancy rate (ASRM 2020 guideline). The first FAQ answer below adds advanced endometriosis to the situations that can change the decision. Male-factor infertility and IVF explains when the semen findings change that balance.

What the Process Looks Like

Most of a cycle is preparation and monitoring. The insemination itself takes only a minute or two.

1. Baseline checks: An ultrasound and, when needed, hormone tests at the start of the cycle.
2. Stimulation and monitoring: If medicine is used, drugs such as letrozole or clomiphene are combined with ultrasound of the growing follicles.
3. Sperm preparation: The laboratory processes the sample and concentrates motile sperm.
4. Insemination: A thin catheter places the prepared sperm in the uterus in a brief procedure.
5. Follow-up: A blood hCG test is usually arranged about two weeks after insemination.

Safety depends on monitoring, especially when gonadotropins (injectable FSH and LH medicines) are used. HFEA guidance and the ASRM opinion on multiple pregnancy support tracking follicles on ultrasound (HFEA guidance; ASRM 2022 multiple gestation opinion). For women under 40 having treatment without IVF, ASRM advises considering cancelling the cycle if more than two follicles of 16 mm or larger, or more than three of 14 mm or larger, develop. Age and baseline risk also shape the decision (ASRM 2022 multiple gestation opinion).

What Success Rates Really Mean

The useful figure is clinical pregnancy per IUI cycle: a pregnancy seen on ultrasound. The live-birth rate is lower, because some pregnancies do not continue.

The chance per cycle tends to fall as the woman’s age rises. It also depends on ovarian response, diagnosis, protocol and sperm parameters, so a group figure is not a personal prediction. Both ASRM and ESHRE mention age when weighing IUI against IVF (ASRM 2020 guideline; ESHRE unexplained infertility guideline).

Comparing IUI Outcomes with IVF Metrics

IUI and IVF count different things. IUI measures clinical pregnancy per insemination cycle. Our IVF success rates by age page reports IVF outcomes per embryo transfer.

IVF differs in how it works: fertilisation takes place in the laboratory, embryos can be assessed before transfer, and the tubes and some sperm–egg barriers are bypassed. A per-cycle IUI figure and a per-transfer IVF figure therefore answer different questions. In terms of guidance, ESHRE considers IVF probably not preferable to IUI with ovarian stimulation as a first step in unexplained infertility, and leaves the choice to factors such as age and how long the couple has been trying (ESHRE unexplained infertility guideline).

Risks and Limitations

IUI is generally well tolerated. Three points are worth discussing before a stimulated cycle:

• Multiple pregnancy: The principal risk in stimulated cycles. Ultrasound monitoring, and a willingness to cancel or defer a cycle when the response is too strong, reduce this risk (ASRM 2022 multiple gestation opinion).
• Ovarian hyperstimulation syndrome (OHSS): Swollen, painful ovaries after stimulation. Uncommon with oral medicine, but watched closely when gonadotropins are prescribed (HFEA guidance).
• Infection and discomfort: Infection after catheter placement is very uncommon (HFEA guidance). Mild, short-lived cramping can occur during or shortly after the procedure.

The other limitation is fit: if the four checks described earlier are not met, recognising that early can prevent a long detour.

When It Makes Sense to Move On

In unexplained infertility, the plan is usually reviewed after three or four well-timed cycles, and earlier when time matters more (ASRM 2020 guideline). It is a review point, not a timetable every couple has to complete.

Age, ovarian reserve, how the ovaries responded and the processed sperm count all feed into that review. AMH is a blood test that helps estimate ovarian reserve. Antral follicle count is the number of small follicles seen on ultrasound.

The discussion may then turn to IVF, with ICSI considered when the clinical picture calls for it. Typical reasons include:

• no pregnancy after three or four well-timed IUI attempts
• time pressure because of age or ovarian reserve
• AMH or antral follicle count pointing to reduced ovarian reserve
• processed total motile sperm below 5 million, when the chance with IUI may be limited and assisted reproduction such as IVF can be discussed (AUA/ASRM 2020 male infertility guideline)

Frequently Asked Questions for Dr. Aksoy

When do you try IUI if there are about 5–10 million motile sperm after preparation, and when do you go straight to IVF or ICSI?

If we can obtain 5 to 10 million motile sperm after preparation, I do not rule IUI out completely. A few IUI attempts can be reasonable, particularly when the woman is young, the tubes are open, ovulation is regular and there is no other major cause of infertility.

I do not look at the count alone. Progressive motility (how well the sperm swim forward), whether the result repeats on other samples, and how long the couple has been trying also matter.

In a 29-year-old woman with open tubes and no other problem, I may try IUI with 7 million motile sperm after preparation. With the same sperm result, I would consider moving to IVF earlier if pregnancy has been elusive for a long time and there are additional female factors.

When the processed motile count stays below 5 million on repeated tests, IUI success falls. When it is around 1 to 2 million, I usually consider IVF or ICSI more strongly.

Blockage of both tubes, clear tubal damage or advanced endometriosis can also change the treatment decision.

Moving to IVF does not always mean ICSI is required. We choose conventional IVF or ICSI from the sperm findings and the rest of the couple’s picture. Low sperm morphology on its own is not enough for me to recommend ICSI to everyone.

For me, 5 million motile sperm is an important threshold in the decision, not a hard cut-off. Alongside the number, the couple’s whole situation has to be assessed.

What finding makes you change the plan before three or four stimulated IUI cycles?

In unexplained infertility we usually consider moving to IVF after three or four well-planned IUI attempts. But I do not treat that number as something that must be completed.

If the first IUI yielded 8 million motile sperm after preparation, and later attempts keep falling to 1 to 2 million, I reassess whether repeating the same treatment still makes sense.

I also do not wait to finish three or four cycles if a previously missed tubal problem, a hydrosalpinx (a tube swollen with fluid) or significant endometriosis comes to light.

How the ovaries respond to stimulation matters too. If too few follicles develop despite the medicine, or so many develop that a multiple pregnancy becomes a risk, the plan may need to change. When many follicles develop, I do not continue IUI just so the cycle is not wasted. Cancelling that cycle can be safer.

If ovarian reserve is clearly reduced, I look at the expected response, age and the other findings together. I do not conclude that IUI is bound to fail just because AMH is low.

It also matters whether earlier attempts were done under the right conditions: whether ovulation was well timed, enough sperm could be prepared, and follicle growth was adequate. Counting failed IUI cycles without that information can mislead.

What matters to me is not having done four IUI cycles. It is whether continuing the same method still offers the couple a meaningful chance of pregnancy. If that chance has clearly fallen, or a new problem has been found, I change the plan earlier.

Why do you not routinely recommend natural-cycle IUI for unexplained infertility, and when would you still consider it?

I do not routinely recommend natural-cycle IUI in unexplained infertility because the extra contribution to the chance of pregnancy is quite limited.

These couples already ovulate, have open tubes and a semen assessment considered normal. In a natural-cycle IUI we mainly prepare the sperm and place them in the uterus at ovulation. Studies have not shown that this meaningfully increases the chance of a live birth compared with continuing intercourse on the fertile days.

By contrast, controlled ovarian stimulation with a medicine such as letrozole or clomiphene, followed by IUI, can increase the chance of pregnancy. Several follicles and the risk of a multiple pregnancy still have to be watched.

Does that mean I never use natural-cycle IUI? No. It can be considered in some specific situations. If the couple has difficulty with intercourse, or the man has an ejaculation problem, and the woman ovulates normally with open tubes, it can make sense. The aim then is to get sperm into the female reproductive tract, not to treat unexplained infertility.

It can also be discussed when a couple does not want ovarian stimulation, or medicine is not suitable. In that case I explain clearly that the expected benefit of natural-cycle IUI is limited.

In unexplained infertility I find it more useful, in suitable couples, either to wait a while for a spontaneous pregnancy, or, if treatment is needed, to do IUI with controlled stimulation.

Sources

• American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline (2020).
• American Society for Reproductive Medicine. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II (2020).
• ESHRE Guideline Group on Unexplained Infertility. Unexplained infertility guideline.
• Human Fertilisation and Embryology Authority. Intrauterine insemination (IUI) treatment guidance.
• American Society for Reproductive Medicine. Multiple gestation associated with infertility therapy: a committee opinion (2022).

Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed · ORCID · LinkedIn

Read full profile → Instagram YouTube

The content has been created by Dr. Senai Aksoy and medically approved.